EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proteomic subtyping of Alzheimer's disease CSF links blood–brain barrier dysfunction to reduced levels of tau and synaptic biomarkers

Madison C Bangs, Joshna Gadhavi, E Kathleen Carter, Lingyan Ping, Duc M Duong, Eric B Dammer, Fang Wu, Anantharaman Shantaraman, Edward J Fox, Erik C B Johnson, James J Lah, Allan I Levey und 1 weitere

Alzheimer's & Dementia · 2025-11 · 21 (11)

DOI: 10.1002/alz.70830 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 03.11.2025. Verfasst von Madison C Bangs und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, School of Medicine, Emory University, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, tau Proteins, Proteomics, Blood-Brain Barrier. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIGMS NIH HHS, BrightFocus Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Alzheimer's disease (AD) shows clinical and molecular heterogeneity shaped by demographic and genetic factors. METHODS To resolve this heterogeneity, we performed a network‐based proteomic analysis of cerebrospinal fluid (CSF) from 431 individuals, including 111 African Americans, to identify protein co‐expression modules and define AD subtypes. RESULTS Ten co‐expression modules reflecting diverse pathways and cell types were identified, many linked to demographics and AD biomarkers. One subtype, enriched in African Americans and males, showed low CSF tau, elevated plasma proteins, and reduced synaptic proteins, features consistent with blood–brain barrier (BBB) dysfunction. This subtype also showed the highest levels of thrombin activity, capable of cleaving tau. Introducing plasma into CSF ex vivo recapitulated the BBB subtype signature, supporting a causal role for plasma proteases in tau and synaptic protein depletion. CONCLUSION These findings link BBB dysfunction and plasma proteases to CSF tau loss and highlight the need for diversity in AD‐biomarker research. Highlights Race and sex correlate with key AD proteomic network modules. We identify six proteomic subtypes with distinct demographic and AD biomarker profiles. Subtype 3 demonstrates an A+/T− phenotype and a profile suggestive of BBB dysfunction. Low CSF tau and neuronal proteins may stem from infiltrating plasma protease cleavage. Plasma spike‐in experiments show decreased endogenous CSF tau and neuronal proteins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer Diseasetau ProteinsProteomicsBlood-Brain BarrierHumansBiomarkersMaleFemaleAgedBlack or African AmericanMiddle AgedAged, 80 and overSynapsesWhite

Stichwörter der Autor:innen

blood–brain barriercentral nervous systemdiagnosisnervous systemnervous system diseasesneurobiologyneurodegenerativeneurodegenerative tauopathiesneurologyprognosis

Substanzen

tau ProteinsBiomarkers

Autor:innen und Institutionen

  • Department of Biochemistry, School of Medicine, Emory University, Atlanta, Georgia, USA.
  • Center for Neurodegenerative Disease Center, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, USA.

Förderung

  • NIA NIH HHS
  • NIGMS NIH HHS
  • BrightFocus Foundation
  • Foundation for the National Institutes of Health
  • National Institute on Aging

Zitieren

APA

Bangs, M. C., Gadhavi, J., Carter, E. K., Ping, L., Duong, D. M., Dammer, E. B., Wu, F., Shantaraman, A., Fox, E. J., Johnson, E. C. B., Lah, J. J., Levey, A. I., & Seyfried, N. T. (2025). Proteomic subtyping of Alzheimer's disease CSF links blood–brain barrier dysfunction to reduced levels of tau and synaptic biomarkers. Alzheimer's & Dementia, 21(11). https://doi.org/10.1002/alz.70830

Vancouver

Bangs MC, Gadhavi J, Carter EK, Ping L, Duong DM, Dammer EB, et al. Proteomic subtyping of Alzheimer's disease CSF links blood–brain barrier dysfunction to reduced levels of tau and synaptic biomarkers. Alzheimer's & Dementia. 2025;21(11). doi:10.1002/alz.70830

BibTeX
@article{Bangs2025,
  author = {Bangs, Madison C and Gadhavi, Joshna and Carter, E Kathleen and Ping, Lingyan and Duong, Duc M and Dammer, Eric B and Wu, Fang and Shantaraman, Anantharaman and Fox, Edward J and Johnson, Erik C B and Lah, James J and Levey, Allan I and Seyfried, Nicholas T},
  title = {Proteomic subtyping of Alzheimer's disease CSF links blood–brain barrier dysfunction to reduced levels of tau and synaptic biomarkers},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  volume = {21},
  number = {11},
  doi = {10.1002/alz.70830}
}
Kostenlos starten →